Track the 佰仁医疗 share price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 佰仁医疗 has published 18 public disclosures. Market capitalisation: €11bn. The latest transaction was disclosed on 2 January 2025 (Purchase). Among the most active insiders: 吴嘉. Every trade is openly available.
18
Insider Decl.
n/a
Thresholds
€901,932
6 ops.
Buy Volume
€290,659
12 ops.
Sell Volume
10Σ signal
Buys €901,932€290,659 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,759 of 29,065 companies
58.0
score / 100
Value
30
Quality
86
FCF yld0.6%
Earn yld1.8%
EV/EBITDA44.3x
ROE15%
Gross mgn89%
Net mgn31%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
